The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). - Concepedia

Concepedia

Publication | Closed Access

The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

72

Citations

0

References

2000

Year

Michele Ghielmini, S F Schmitz, Kurt Bürki, Gabriella Pichert, Daniel Betticher, Roger Stupp, Martin Wernli, Andreas Lohri, Doris Schmitter, Francesco Bertoni,

Abstract

Rituximab is an active agent for the treatment of FL, while its efficacy is modest in MCL. The effect in reducing minimal residual disease is more pronounced on the blood than it is on the bone marrow.